USA flag logo/image

An Official Website of the United States Government

Company Information:

Company Name:
TRANSLATIONAL SCIENCES, INC.
Address:
1840 Overton Park Avenue
Memphis, TN
Phone:
N/A
URL:
N/A
EIN:
126057441
DUNS:
803592364
Number of Employees:
N/A
Woman-Owned?:
No
Minority-Owned?:
No
HUBZone-Owned?:
No

Commercialization:

Has been acquired/merged with?:
N/A
Has had Spin-off?:
N/A
Has Had IPO?:
N/A
Year of IPO:
N/A
Has Patents?:
N/A
Number of Patents:
N/A
Total Sales to Date $:
$ 0.00
Total Investment to Date $
$ 0.00
POC Title:
N/A
POC Name:
N/A
POC Phone:
N/A
POC Email:
N/A
Narrative:
N/A

Award Totals:

Program/Phase Award Amount ($) Number of Awards
SBIR Phase I $300,000.00 1
SBIR Phase II $2,999,979.00 1
STTR Phase I $167,685.00 1
STTR Phase II $1,519,440.00 1

Award List:

Novel Methods for Dissolving Blood Clots

Award Year / Program / Phase:
2010 / STTR / Phase I
Award Amount:
$167,685.00
Agency:
HHS
Principal Investigator:
Guy L. Reed – 617-432-4992
Research Institution:
University Of Tennessee Health Sci Ctr
RI Contact:
Abstract:
DESCRIPTION (provided by applicant): Cardiovascular disease is the leading cause of death worldwide. Current therapies for cardiovascular disease are associated with partial success, restricted access, delays, possible neurotoxicity and other important limitations. Our goal is to develop a novel… More

Reducing Stroke by a Novel, Clot-dissolving Antibody

Award Year / Program / Phase:
2011 / SBIR / Phase I
Award Amount:
$300,000.00
Agency:
HHS
Principal Investigator:
Paul H. Kussie – 706-421-3355
Abstract:
DESCRIPTION (provided by applicant): Stroke is the 3rd leading cause of death and the primary cause of severe, long term disability. Each year 795,000 Americans have a stroke and the annual costs to the economy are 57.9 billion. The vast majority of acute ischemic strokes are caused by a thrombus… More

Reducing Stroke by a Novel, Clot-dissolving Antibody

Award Year / Program / Phase:
2012 / SBIR / Phase II
Award Amount:
$2,999,979.00
Agency:
HHS
Principal Investigator:
Paul H. Kussie – 901-274-4506
Abstract:
DESCRIPTION (provided by applicant): Stroke is the 3rd leading cause of death and the primary cause of severe, long term disability. Each year 795,000 Americans have a stroke and the annual costs to the economy are 57.9 billion. The vast majority of acute ischemic strokes are caused by a thrombus… More

Novel Methods for Dissolving Blood Clots

Award Year / Program / Phase:
2012 / STTR / Phase II
Award Amount:
$1,519,440.00
Agency:
HHS
Principal Investigator:
Guy L. Reed – 617-432-4992
Research Institution:
UNIVERSITY OF WISCONSIN SYSTEM
RI Contact:
Abstract:
DESCRIPTION (provided by applicant): Each year, as many as 2 million Americans develop venous thromboembolism (VTE). VTEs are blood clots in the legs (venous thrombosis) that may travel to the lungs (pulmonary embolism). It is estimated that 10-20% of VTEpatients die, and the annual direct costs are… More